UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

BMC cancer, 2009-05, Vol.9 (146), p.146-146, Article 146

2009

Volltextzugriff (PDF)

Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity

Molecular cancer therapeutics, 2009-05, Vol.8 (5), p.1189-1196

2009

Volltextzugriff (PDF)

A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C

Human vaccines & immunotherapeutics, 2017-11, Vol.13 (11), p.2548-2560

2017

Volltextzugriff (PDF)

Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice

International journal of cancer, 2008-01, Vol.122 (1), p.57-62

2008

Volltextzugriff (PDF)

Heberprot-P: a novel product for treating advanced diabetic foot ulcer

MEDICC review, 2013-01, Vol.15 (1), p.11-15

2013

Volltextzugriff (PDF)

Sensitivity of tumor cells towards CIGB-300 anticancer peptide relies on its nucleolar localization

Journal of peptide science, 2012-04, Vol.18 (4), p.215-223

2012

Volltextzugriff (PDF)

Proteomic Profile Regulated by the Anticancer Peptide CIGB-300 in Non-Small Cell Lung Cancer (NSCLC) Cells

Journal of proteome research, 2010-10, Vol.9 (10), p.5473-5483

2010

Volltextzugriff (PDF)

Development and validation of a quantitative ELISA for the measurement of PSA concentration

Clinica chimica acta, 2002-03, Vol.317 (1), p.55-63

2002

Volltextzugriff (PDF)

CIGB-300, a proapoptotic peptide, inhibits angiogenesis in vitro and in vivo

Experimental cell research, 2011-07, Vol.317 (12), p.1677-1688

2011

Volltextzugriff (PDF)

Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice

Angiogenesis (London), 2007-03, Vol.10 (1), p.23-34

2007

Volltextzugriff (PDF)

Type 2 Diabetes Mellitus (T2DM): Biological Overview from Pathways to Organelles and its Translation toward a Torpid Wound Healing Process

Journal of diabetes & metabolism, 2013-08, Vol.4 (7)

2013

Volltextzugriff (PDF)

Diversity of Senile Plaques in Alzheimers Disease as Revealed by a New Monoclonal Antibody that Recognizes an Internal Sequence of the Aβ Peptide

Current Alzheimer research, 2005-10, Vol.2 (4), p.409-417

2005

Volltextzugriff (PDF)

Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein Kinase 2 (casein Kinase 2)

Cancer research (Chicago, Ill.), 2004-10, Vol.64 (19), p.7127-7129

2004

Volltextzugriff (PDF)

CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo

Molecular and cellular biochemistry, 2008-09, Vol.316 (1-2), p.163-167

2008

Volltextzugriff (PDF)

Micro- and nanoporous materials capable of absorbing solvents and oils reversibly： the state of the art

Petroleum science, 2017-02, Vol.14 (1), p.84-104

2017

Volltextzugriff (PDF)

Abstract 1376: Antiangiogenic properties of the peptide CIGB-300

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1376-1376

2010

Volltextzugriff (PDF)

One-step immunochromatographic assay for screening of coeliac disease

The Lancet (British edition), 2002-03, Vol.359 (9310), p.945-946

2002

Volltextzugriff (PDF)

Taking stock of Cuban biotech

Nature biotechnology, 2007-11, Vol.25 (11), p.1215-1216

2007

Volltextzugriff (PDF)

Fast and novel purification method to obtain the prostate specific antigen (PSA) from human seminal plasma

The Prostate, 2006-07, Vol.66 (10), p.1029-1036

2006

Volltextzugriff (PDF)

Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti-hepatitis B vaccination

The journal of gene medicine, 2010-01, Vol.12 (1), p.107-116

2010

Volltextzugriff (PDF)

Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF32-51 region

Journal of peptide science, 2010-01, Vol.16 (1), p.40-47

2010

Volltextzugriff (PDF)

Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF(32-51) region

Journal of peptide science, 2010-01, Vol.16 (1), p.40

2010

Volltextzugriff (PDF)

Non-clinical toxicological studies carried out of a new biomolecule with anti tumoural effect

Toxicology letters, 2008-10, Vol.180, p.S46-S46

2008

Volltextzugriff (PDF)

Heberprot-P: A Novel Product for Treating Advanced Diabetic Foot Ulcer

MEDICC review, 2013, Vol.15 (1), p.11-15

2013

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(26)
Humans
(22)
Animals
(13)
Mice
(12)
Cell Line, Tumor
(11)
Biological And Medical Sciences
(9)
Biotechnology & Applied Microbiology
(9)
Female
(8)
Oncology
(8)
Peptides, Cyclic - Pharmacology
(8)
Apoptosis
(7)
Physical Sciences
(7)
Apoptosis - Drug Effects
(6)
Chemistry
(6)
Male
(6)
Medical Sciences
(6)
Antineoplastic Agents - Pharmacology
(5)
Biochemistry & Molecular Biology
(5)
Cell Biology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity

A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C

Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice

Heberprot-P: a novel product for treating advanced diabetic foot ulcer

Sensitivity of tumor cells towards CIGB-300 anticancer peptide relies on its nucleolar localization

Proteomic Profile Regulated by the Anticancer Peptide CIGB-300 in Non-Small Cell Lung Cancer (NSCLC) Cells

Development and validation of a quantitative ELISA for the measurement of PSA concentration

CIGB-300, a proapoptotic peptide, inhibits angiogenesis in vitro and in vivo

Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice

Type 2 Diabetes Mellitus (T2DM): Biological Overview from Pathways to Organelles and its Translation toward a Torpid Wound Healing Process

Diversity of Senile Plaques in Alzheimers Disease as Revealed by a New Monoclonal Antibody that Recognizes an Internal Sequence of the Aβ Peptide

Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein Kinase 2 (casein Kinase 2)

CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo

CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research

Micro- and nanoporous materials capable of absorbing solvents and oils reversibly： the state of the art

Abstract 1376: Antiangiogenic properties of the peptide CIGB-300

One-step immunochromatographic assay for screening of coeliac disease

Taking stock of Cuban biotech

Fast and novel purification method to obtain the prostate specific antigen (PSA) from human seminal plasma

Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti-hepatitis B vaccination

Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF32-51 region

Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF(32-51) region

Non-clinical toxicological studies carried out of a new biomolecule with anti tumoural effect

Heberprot-P: A Novel Product for Treating Advanced Diabetic Foot Ulcer

Suchergebnisse filtern